ProPhase Labs, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRPH research report →
Companywww.prophaselabs.com
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products.
- CEO
- Ted William Karkus
- IPO
- 1994
- Employees
- 96
- HQ
- Garden City, NY, US
Price Chart
Valuation
- Market Cap
- $475.36K
- P/E
- -0.01
- P/S
- 0.44
- P/B
- 0.06
- EV/EBITDA
- -0.31
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 191.36%
- Op Margin
- -2496.56%
- Net Margin
- -3872.24%
- ROE
- -404.42%
- ROIC
- -156.93%
Growth & Income
- Revenue
- $6.77M · -84.75%
- Net Income
- $-53,364,000 · -217.98%
- EPS
- $-26.10 · -166.33%
- Op Income
- $-38,629,000
- FCF YoY
- -27.17%
Performance & Tape
- 52W High
- $6.70
- 52W Low
- $0.07
- 50D MA
- $0.11
- 200D MA
- $1.75
- Beta
- 0.17
- Avg Volume
- 168.43K
Get TickerSpark's AI analysis on PRPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 20, 25 | Abenante Carolina | other | 0 |
| Sep 9, 25 | Karkus Ted William | other | 500,000 |
| Feb 17, 25 | Hollenshead Stuart | other | 500,000 |
| Jan 27, 25 | Hollenshead Stuart | other | 0 |
| Feb 14, 25 | Hirsch Warren | other | 100,000 |
| Feb 14, 25 | GLECKEL LOUIS MD | other | 100,000 |
| Mar 17, 24 | Karkus Ted William | other | 400,000 |
| Jan 1, 24 | Latkin Jed | other | 500,000 |
| Jan 1, 24 | Latkin Jed | other | 0 |
| Mar 17, 24 | Hirsch Warren | other | 70,000 |
Our PRPH Coverage
We haven't published any research on PRPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PRPH Report →